Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemonoxacin vs Levofloxacin in CAP
NCT00434291Phase 2Completed
- Sponsor
- TaiGen Biotechnology Co., Ltd.
- Start
- Dec 2006
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of nemonoxacin in community acquired pneumonia (CAP), sponsored by TaiGen Biotechnology Co., Ltd.. Started Dec 2006; status: completed.
02
Drugs
nemonoxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00434291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434291.